Versant Capital Management Inc Acquires 228 Shares of The Allstate Co. (NYSE:ALL)

Versant Capital Management Inc increased its holdings in The Allstate Co. (NYSE:ALLFree Report) by 146.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 384 shares of the insurance provider’s stock after purchasing an additional 228 shares during the period. Versant Capital Management Inc’s holdings in Allstate were worth $74,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of ALL. SPC Financial Inc. grew its position in shares of Allstate by 3.6% in the 3rd quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock valued at $297,000 after buying an additional 54 shares during the last quarter. Lake Street Advisors Group LLC boosted its holdings in Allstate by 1.8% in the third quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock valued at $596,000 after acquiring an additional 54 shares during the last quarter. Abacus Planning Group Inc. increased its position in Allstate by 2.4% during the 3rd quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock valued at $458,000 after purchasing an additional 56 shares during the period. Chicago Partners Investment Group LLC increased its position in Allstate by 1.3% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock valued at $893,000 after purchasing an additional 59 shares during the period. Finally, Carmichael Hill & Associates Inc. raised its holdings in Allstate by 15.0% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock worth $87,000 after purchasing an additional 60 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Price Performance

ALL stock opened at $191.45 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The business has a 50-day simple moving average of $195.86 and a two-hundred day simple moving average of $184.46. The company has a market capitalization of $50.70 billion, a P/E ratio of 12.40, a price-to-earnings-growth ratio of 1.70 and a beta of 0.52. The Allstate Co. has a 52-week low of $147.08 and a 52-week high of $209.88.

Allstate (NYSE:ALLGet Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same quarter in the prior year, the company posted $0.81 earnings per share. Allstate’s revenue was up 14.7% compared to the same quarter last year. Research analysts expect that The Allstate Co. will post 16.26 EPS for the current fiscal year.

Allstate Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.92%. The ex-dividend date was Friday, November 29th. Allstate’s payout ratio is currently 23.83%.

Analyst Upgrades and Downgrades

ALL has been the subject of a number of analyst reports. Wells Fargo & Company lifted their target price on shares of Allstate from $175.00 to $186.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 5th. UBS Group lifted their price objective on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. upped their target price on Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Evercore ISI lifted their target price on Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a report on Wednesday, October 9th. Finally, Keefe, Bruyette & Woods increased their price target on Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $217.19.

Check Out Our Latest Stock Analysis on Allstate

About Allstate

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.